Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Finn

Showing results (341-350 of 527) with videos related to

Pageof 53
Sort By:
Liver Cancer|August 18, 2015
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular CarcinomaJean-Luc Raoul, Joong-Won Park, Yoon-Koo Kang, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasmaDavid W Haas, Benjamin Johnson, Janet Nicotera, et al.
Progress in Neurobiology|June 9, 2020
Layer-dependent functional connectivity methodsLaurentius Huber, Emily S Finn, Yuhui Chai, et al.
Breast Cancer Research : BCR|October 31, 2009
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroRichard S Finn, Judy Dering, Dylan Conklin, et al.
Plos One|April 25, 2025
Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylationRan Hu, Benjamin Tran, Shuo Li, et al.
Liver Cancer|December 7, 2023
Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-AnalysisArndt Vogel, Richard S Finn, Marie-Hélène Blanchet Zumofen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2021
Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic TherapiesMasatoshi Kudo, Robert Montal, Richard S Finn, et al.
Pediatric Nephrology (Berlin, Germany)|February 15, 2022
Pathology findings in pediatric patients with COVID-19 and kidney dysfunctionEric Nomura, Laura S Finn, Abbie Bauer, et al.
Neuroimage|December 22, 2019
Sub-millimeter fMRI reveals multiple topographical digit representations that form action maps in human motor cortexLaurentius Huber, Emily S Finn, Daniel A Handwerker, et al.
Pageof 53

Showing results (341-350 of 527) with videos related to

Sort By:
Pageof 53
Liver Cancer|August 18, 2015
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular CarcinomaJean-Luc Raoul, Joong-Won Park, Yoon-Koo Kang, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasmaDavid W Haas, Benjamin Johnson, Janet Nicotera, et al.
Progress in Neurobiology|June 9, 2020
Layer-dependent functional connectivity methodsLaurentius Huber, Emily S Finn, Yuhui Chai, et al.
Breast Cancer Research : BCR|October 31, 2009
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroRichard S Finn, Judy Dering, Dylan Conklin, et al.
Plos One|April 25, 2025
Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylationRan Hu, Benjamin Tran, Shuo Li, et al.
Liver Cancer|December 7, 2023
Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-AnalysisArndt Vogel, Richard S Finn, Marie-Hélène Blanchet Zumofen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2021
Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic TherapiesMasatoshi Kudo, Robert Montal, Richard S Finn, et al.
Pediatric Nephrology (Berlin, Germany)|February 15, 2022
Pathology findings in pediatric patients with COVID-19 and kidney dysfunctionEric Nomura, Laura S Finn, Abbie Bauer, et al.
Neuroimage|December 22, 2019
Sub-millimeter fMRI reveals multiple topographical digit representations that form action maps in human motor cortexLaurentius Huber, Emily S Finn, Daniel A Handwerker, et al.
Pageof 53